Real World Evidence, a substitute for phase IV and late phase III clinical trials that could make earlier introduction of new medicines possible
- In: F11 - The value of real world evidence - will availability of data lead to a paradigm change? on Tuesday, 3 September 2013, 09.00-12.00
- At: Dublin (Ireland) (2013)
- Type: Presentation
- By: LEUFKENS, Bert (University of Utrecht , Netherlands) The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023